BioSpace News Archive

Planet 13 Holdings Inc. (CSE:PLTH) (OTCQB:PLNHF) (“Planet 13" or the “Company”), a leading vertically-integrated Nevada cannabis company, today announced its financial results for the three-month and twelve-month period ended December 31, 2020. Planet 13’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”).

Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), today announced that the National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for a Phase I clinical trial to evaluate safety and tolerability of ATG-019

Increasing adoption of FFR-CT among the healthcare professional is expected to drive the market through 2030

According to the report, the global disposable syringes market was valued at US$ 6.9 Bn in 2019 and is expected to expand at a CAGR of ~7% during the forecast period from 2020 to 2030.

Telemedicine consultations are being highly publicized for the management of dry eye disease amidst the coronavirus pandemic.

Single-use technology has come up as one of the prominent technologies in the sector of pre-commercial manufacturing, which comprises both clinical and pre-clinical scales.

The demand within the global immunoprotein diagnostic market is slated to reach unprecedented heights in the years to follow.

Akoya Biosciences, Inc., The Spatial Biology Company ® , today announced the appointment of Frederic Pla, PhD, as Chief Operating Officer. Dr. Pla will play a key role in preparing the company as it scales to serve the needs of discovery and clinical researchers adopting spatial biology. This press release features multimedia. View the

Advantech, a global leader of advanced IoT intelligence systems and embedded platforms, is pleased to announce the launch of its One-to-One Visitor Thermal Screening Kiosk, the cost effective version of its Visitor Thermal Screening System that was released in 2020.

Cardiac Insight, Inc., a healthcare innovator specializing in wearable electrocardiogram (ECG) cardiac sensors and proven automated ECG analysis that delivers innovative solutions and highly differentiated benefits to healthcare providers, clinicians, and patients, reported over a 70% surge in sales of its market leading Cardea 20/20 ECG